The Evaluation of Intralesional Glucantime and Cryotherapy plus Intralesional Glucantime Therapeutic Efficacy on Zoonotic Cutaneous Leishmaniasis: A Randomized Clinical Trial

Background: Currently, Glucantime is considered the first-line treatment of cutaneous Leishmaniasis. This study aimed to evaluation of intralesional Glucantime (IG) and Cryotherapy (Cryo) plus intralesional Glucantime (Cryo and IG) therapeutic efficacy on Zoonotic Cutaneous Leishmaniasis in Qom prov...

Full description

Bibliographic Details
Main Authors: Abedin Saghafipour, Ehssan Mozaffari, Fatemeh Rezaei
Format: Article
Language:English
Published: Mashhad University of Medical Sciences 2017-12-01
Series:International Journal of Pediatrics
Subjects:
Online Access:http://ijp.mums.ac.ir/article_8993_f363c4d707985aa263028129a52a68d7.pdf
id doaj-c183faa407c24a0abdbd4ed97a6c4dff
record_format Article
spelling doaj-c183faa407c24a0abdbd4ed97a6c4dff2020-11-25T01:30:44ZengMashhad University of Medical SciencesInternational Journal of Pediatrics2345-50472345-50552017-12-015126689669710.22038/ijp.2017.24545.20698993The Evaluation of Intralesional Glucantime and Cryotherapy plus Intralesional Glucantime Therapeutic Efficacy on Zoonotic Cutaneous Leishmaniasis: A Randomized Clinical TrialAbedin Saghafipour0Ehssan Mozaffari1Fatemeh Rezaei2Department of Public Health, Faculty of Health, Qom University of Medical Sciences, Qom, Iran.Department of Medical Entomology and Vector Control, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.Department of Social Medicine, Medical School, Jahrom University of Medical Sciences, Jahrom, Iran.Background: Currently, Glucantime is considered the first-line treatment of cutaneous Leishmaniasis. This study aimed to evaluation of intralesional Glucantime (IG) and Cryotherapy (Cryo) plus intralesional Glucantime (Cryo and IG) therapeutic efficacy on Zoonotic Cutaneous Leishmaniasis in Qom province, Iran. Materials and Methods: In this randomized controlled trial of 197 CL patients reported from Qom health centers, Iran during (2014-2017), 112 cases were entered to this study. According to the Iranian Ministry of Health therapeutic guide line of CL, 54 cases with 116 lesions received IG weekly, and 58 patients with 115 lesions received the IG once a week coupled with Cryo using liquid nitrogen once every two weeks. The average volume of injected solution per lesion was 0.2 ml to 0.5 ml into the border of the healthy skin and the onset of erythema in the lesions using insulin syringe needles. In second therapeutic method; cryotherapy with liquid nitrogen was performed by dipstick technique. At first, the lesion size and induration of lesions were recorded. After 7 and 12 weeks of treatment, lesions healing rate was monitored. Healing was defined as complete re-epithelialization and disappearance of induration. Results: Out of 112 CL patients, 54 cases with 116 lesions received IG, and 58 patients with 115 lesions received Cryo and IG. At 7th week after the initiation of treatment, complete healing was observed in 56 out of 116 lesions (48.1%) in the group which received weekly IG and 83 out of 115 lesions (72.2%) in the group which received biweekly Cryo plus IG. At 12th week after the treatment, the cure rate was 91% and 100% in group which received weekly IG and group which received IG once a week coupled with cryotherapy (p=0.001). Conclusion: Based on the findings, IG once a week coupled with cryotherapy was more effective compared with weekly IG and reduced the period of treatment.http://ijp.mums.ac.ir/article_8993_f363c4d707985aa263028129a52a68d7.pdfCutaneous LeishmaniasisCryotherapyIntralesional Glucantime
collection DOAJ
language English
format Article
sources DOAJ
author Abedin Saghafipour
Ehssan Mozaffari
Fatemeh Rezaei
spellingShingle Abedin Saghafipour
Ehssan Mozaffari
Fatemeh Rezaei
The Evaluation of Intralesional Glucantime and Cryotherapy plus Intralesional Glucantime Therapeutic Efficacy on Zoonotic Cutaneous Leishmaniasis: A Randomized Clinical Trial
International Journal of Pediatrics
Cutaneous Leishmaniasis
Cryotherapy
Intralesional Glucantime
author_facet Abedin Saghafipour
Ehssan Mozaffari
Fatemeh Rezaei
author_sort Abedin Saghafipour
title The Evaluation of Intralesional Glucantime and Cryotherapy plus Intralesional Glucantime Therapeutic Efficacy on Zoonotic Cutaneous Leishmaniasis: A Randomized Clinical Trial
title_short The Evaluation of Intralesional Glucantime and Cryotherapy plus Intralesional Glucantime Therapeutic Efficacy on Zoonotic Cutaneous Leishmaniasis: A Randomized Clinical Trial
title_full The Evaluation of Intralesional Glucantime and Cryotherapy plus Intralesional Glucantime Therapeutic Efficacy on Zoonotic Cutaneous Leishmaniasis: A Randomized Clinical Trial
title_fullStr The Evaluation of Intralesional Glucantime and Cryotherapy plus Intralesional Glucantime Therapeutic Efficacy on Zoonotic Cutaneous Leishmaniasis: A Randomized Clinical Trial
title_full_unstemmed The Evaluation of Intralesional Glucantime and Cryotherapy plus Intralesional Glucantime Therapeutic Efficacy on Zoonotic Cutaneous Leishmaniasis: A Randomized Clinical Trial
title_sort evaluation of intralesional glucantime and cryotherapy plus intralesional glucantime therapeutic efficacy on zoonotic cutaneous leishmaniasis: a randomized clinical trial
publisher Mashhad University of Medical Sciences
series International Journal of Pediatrics
issn 2345-5047
2345-5055
publishDate 2017-12-01
description Background: Currently, Glucantime is considered the first-line treatment of cutaneous Leishmaniasis. This study aimed to evaluation of intralesional Glucantime (IG) and Cryotherapy (Cryo) plus intralesional Glucantime (Cryo and IG) therapeutic efficacy on Zoonotic Cutaneous Leishmaniasis in Qom province, Iran. Materials and Methods: In this randomized controlled trial of 197 CL patients reported from Qom health centers, Iran during (2014-2017), 112 cases were entered to this study. According to the Iranian Ministry of Health therapeutic guide line of CL, 54 cases with 116 lesions received IG weekly, and 58 patients with 115 lesions received the IG once a week coupled with Cryo using liquid nitrogen once every two weeks. The average volume of injected solution per lesion was 0.2 ml to 0.5 ml into the border of the healthy skin and the onset of erythema in the lesions using insulin syringe needles. In second therapeutic method; cryotherapy with liquid nitrogen was performed by dipstick technique. At first, the lesion size and induration of lesions were recorded. After 7 and 12 weeks of treatment, lesions healing rate was monitored. Healing was defined as complete re-epithelialization and disappearance of induration. Results: Out of 112 CL patients, 54 cases with 116 lesions received IG, and 58 patients with 115 lesions received Cryo and IG. At 7th week after the initiation of treatment, complete healing was observed in 56 out of 116 lesions (48.1%) in the group which received weekly IG and 83 out of 115 lesions (72.2%) in the group which received biweekly Cryo plus IG. At 12th week after the treatment, the cure rate was 91% and 100% in group which received weekly IG and group which received IG once a week coupled with cryotherapy (p=0.001). Conclusion: Based on the findings, IG once a week coupled with cryotherapy was more effective compared with weekly IG and reduced the period of treatment.
topic Cutaneous Leishmaniasis
Cryotherapy
Intralesional Glucantime
url http://ijp.mums.ac.ir/article_8993_f363c4d707985aa263028129a52a68d7.pdf
work_keys_str_mv AT abedinsaghafipour theevaluationofintralesionalglucantimeandcryotherapyplusintralesionalglucantimetherapeuticefficacyonzoonoticcutaneousleishmaniasisarandomizedclinicaltrial
AT ehssanmozaffari theevaluationofintralesionalglucantimeandcryotherapyplusintralesionalglucantimetherapeuticefficacyonzoonoticcutaneousleishmaniasisarandomizedclinicaltrial
AT fatemehrezaei theevaluationofintralesionalglucantimeandcryotherapyplusintralesionalglucantimetherapeuticefficacyonzoonoticcutaneousleishmaniasisarandomizedclinicaltrial
AT abedinsaghafipour evaluationofintralesionalglucantimeandcryotherapyplusintralesionalglucantimetherapeuticefficacyonzoonoticcutaneousleishmaniasisarandomizedclinicaltrial
AT ehssanmozaffari evaluationofintralesionalglucantimeandcryotherapyplusintralesionalglucantimetherapeuticefficacyonzoonoticcutaneousleishmaniasisarandomizedclinicaltrial
AT fatemehrezaei evaluationofintralesionalglucantimeandcryotherapyplusintralesionalglucantimetherapeuticefficacyonzoonoticcutaneousleishmaniasisarandomizedclinicaltrial
_version_ 1725090247935524864